MANAGEMENT

Daniel J. Petrarca - Chairman and CEO

Mr. Petrarca formally joined Opticon as its CEO in July 2004 and is responsible for all areas of leadership of the Company. From 1991 to 1998 he was a Founder and Vice President of Global Therapeutics, Inc., a company that designed and manufactured angioplasty balloons and coronary stents. Global Therapeutics was sold to Cook, Inc. in 1998.

At Global Therapeutics, Mr. Petrarca was responsible for top management of a broad spectrum of company activities. These included: developing a world-wide sales, distribution and training organization; organizing and completing clinical trials in the U.S. and abroad; establishing and managing budgets for various operating segments of the business; establishing and managing manufacturing including inventory control, production, sterilization, testing and contract negotiations; and assisting in obtaining FDA and CE marking approvals worldwide.

Following the sale of Global Therapeutics, Mr. Petrarca became Director, Clinical Development for Cook, Inc. with respect to the business of the recently-sold company. In this capacity he reviewed all new coronary product ideas in this field for potential investment, established all clinical sites worldwide for cardiology products, directed the marketing of new clinical products and trained the sale force handling the former Global Therapeutics products.

Prior to Global Therapeutics, Mr. Petrarca was employed in several sales and sales management roles for three cardiology and radiology product companies.

He has a BS degree in Marketing and Management from Clarion University (PA).

Glenn D. Brunner - President

Mr. Brunner has served as Opticon's President since October 2001. Prior to this position, Mr. Brunner served as Vice President of Product Development from July 2000 to September 2001, after joining the company in May 2000. From 1990 to 2000, Mr. Brunner held several research and development positions with Medex, Inc. and served as its Director of Global Technology through its acquisition by Furon Company and its subsequent reorganization within Saint-Gobain Performance Plastics. In that capacity, Mr. Brunner had worldwide responsibility for the development of all patient monitoring, fluid and drug delivery infusion systems, and cardiovascular products and was also responsible for the management of all intellectual properties. Prior to entering the medical device industry, Mr. Brunner held positions as Research Fellow in the Biomedical Engineering Center at The Ohio State University, and as Design Engineer for Telesis Controls Corporation, a developer of industrial marking and tracking systems. Mr. Brunner received a BE in Electrical Engineering from the University of Dayton and his MS in Biomedical Engineering from The Ohio State University.

David J. Lundquist - Director

In addition to co-founding the investor group that acquired control of Opticon Medical's business with Mr. Post in March 2002, Mr. Lundquist has been Managing Partner of Lundquist, Schiltz & Associates, Inc., an investment advisory company, since January 1996. From 1991 to 1996, Mr. Lundquist was Vice Chairman and Chief Financial Officer of New Heritage Associates, a company engaged in the acquisition and operation of cable television systems. Mr. Lundquist was Executive Vice President - Finance of Heritage Communications, Inc., from 1980 to 1990. Prior to joining Heritage, Mr. Lundquist was the Vice President - Finance for a computer services company in Omaha. Mr. Lundquist is Vice Chairman of Da-Lite Screen Company, a manufacturer of movie screens and other meeting-room products. He serves on the Board of Directors of Genesis Systems Group, Ltd, a growth company in industrial robotics software and hardware systems; MARKETLINK, a telemarketing company; and Universal Blanchers, a peanut processing company. Mr. Lundquist attended Harvard University and graduated from the University of Minnesota with a degree in economics. He received his MBA degree from Stanford University Graduate School of Business with a concentration in finance.

Gary M. Post - Vice President, Finance and Director

Mr. Post co-founded the investor group that acquired control of Opticon Medical with Mr. Lundquist in March 2002 and has been part of the management team since this investment group acquired the Opticon Medical assets in July 2002. He served as Acting CEO of Opticon from July 2002 to August 2003. Mr. Post also serves as a Managing Director of Ambient Advisors, LLC, an investment banking firm based in Los Angeles and has over 20 years experience in investment banking and venture investment, especially in the medical arena. Mr. Post's prior experience has primarily been in investment banking, consulting and corporate investing. He has held senior positions with Drexel Burnham Lambert, Kidder Peabody, Houlihan, Lokey, Howard and Zukin and McKinsey & Company. Mr. Post holds an A.B. degree from Stanford University and received his MBA from the University of California at Los Angeles (UCLA).

Spencer W. Beaufore - Director, Product Development

Mr. Beaufore joined Opticon in April 2000 as Chief Project Engineer before assuming the post of Director, Product Development in July, 2002. From 1990 to 2000, he held several engineering positions including Research and Development Section Manager with Medex, Inc., a fluid and drug infusion systems, patient monitoring and cardiovascular medical device company. As R&D Section Manager, Mr. Beaufore was responsible for the Product Development and New Tooling Procurement Groups and served as the lead engineer for the Specialty Products and OEM Sales groups. Prior to 1990, Mr. Beaufore held a Project Engineer position at Master Industries, a tier-one injection-molding supplier to Ford Motor Company and CAE Designer position at Haworth, Inc., a worldwide manufacturer of office furniture. Mr. Beaufore received a BS in Engineering from Western Michigan University.